col0,col1,col2,col3,col4,col5,col6
VRC 705: A Zika Virus DNA Vaccine in Healthy Adults and Adolescents,infection,2017-03-29,phase II clinical trial,2338,Baylor College of Medicine,National Institute of Allergy and Infectious Diseases
Evaluation of the Safety and Immunogenicity of the Live Attenuated Zika Vaccine rZIKV/D4Δ30-713 in Flavivirus-naïve Adults,Zika fever,2018-07-06,phase I clinical trial,28,Johns Hopkins University,National Institute of Allergy and Infectious Diseases
